Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

Autor: Adela Cañete, Rafael Peris-Bonet, Riccardo Capocaccia, Elena Pardo-Romaguera, Vanessa Segura, Ana Muñoz-López, Ana Fernández-Teijeiro, Jaume Galceran-Padros, Gemma Gatta, F Almazán, AI Benito, MI Buedo, C Calvo, A Cañete, O Cruz, C Esquembre, M Fernández, A Fernández-Teijeiro Álvarez, JL Fuster, M García, C Gil López, J Gómez, A Gondra, M González, H González, B Herrero, A Lassaletta, R López, B López-Ibor Aliño, L Madero, S Maldonado, FJ Mares, C Márquez, ME Mateos, K Melwani, MC Mendoza, L Moreno, ML Moreno, GM Muñoz, MJ Ortega, E Panizo, S Pisa Gatell, R Portugal, M Sagaseta, JA Salinas, A Sastre, M Tallón, M Torrent, JJ Uriz, A Varo, MA Vázquez, JS Vílchez, JA Villegas, JL Vivanco, M Zamora, R Alamo, A Alemán, M Chico, MD Chirlaque, J Galceran, R Marcos, A Mateos, JR Quirós, C Sanchez-Contador, C Sabater

Publikováno v: Cancer Epidemiology. 78:102145

Linkage between clinical databases and population-based cancer registries may serve to evaluate European Reference Networks' (ERNs) activity, by monitoring the proportion of patients benefiting from these and their impact on survival at a population

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bd5b5e6989dd25bf3514796c7f251d
https://doi.org/10.1016/j.canep.2022.102145

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.

Autor: Carrillo-Reixach J; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain., Torrens L; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain., Simon-Coma M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain., Royo L; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain., Domingo-Sàbat M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain., Abril-Fornaguera J; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain., Akers N; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, USA., Sala M; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain; Gastroenterology Department, Hospital Universitari Josep Trueta, Girona, Spain., Ragull S; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain., Arnal M; MARGenomics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Villalmanzo N; PMPPC, IGTP, Badalona, Spain., Cairo S; XenTech, Evry, France; Instituto di Ricerca Pediatrica, Corso Stati Uniti 4, Padova, Italy., Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute, L'Hospitalet del Llobregat, Barcelona, Spain., Kappler R; Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Lindwurmstr. 2a, 80337 Munich, Germany., Garrido M; Hospital Vall d'Hebron, Pathology Department, Barcelona, Spain., Guerra L; University Hospital La Paz, Pathology Department, Madrid, Spain., Sábado C; Hospital Vall d'Hebron, Pediatric Oncology Department, Barcelona, Spain., Guillén G; Hospital Vall d'Hebron, Pediatric Surgery Department, Barcelona, Spain., Mallo M; MDS Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Piñeyro D; High Content Genomics and Bioinformatics Unit, PMPPC, IGTP, Badalona, Spain., Vázquez-Vitali M; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain., Kuchuk O; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Mateos ME; Pediatric Oncology Unit, Department of Pediatrics, University Hospital Reina Sofía, Córdoba, Spain., Ramírez G; University Hospital Universitario Virgen del Rocío, Pediatric Oncology Department, Sevilla, Spain., Santamaría ML; University Hospital La Paz, Pediatric Surgery Department, Madrid, Spain., Mozo Y; University Hospital La Paz, Pediatric Oncology Department, Madrid, Spain., Soriano A; Biomedical Research in Cancer Stem Cells Group, Pathology Department, Institut de Recerca Hospital Vall d'Hebron (VHIR), Barcelona, Spain., Grotzer M; Department of Pediatric Oncology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland., Branchereau S; Bicêtre Hospital, Le Kremlin-Bicêtre, France., de Andoin NG; Pediatric Oncology, Hospital Universitario Donostia, Doctor Begiristain Kalea, 117, 20080, Donostia, Spain., López-Ibor B; Department of Pediatric Hematology and Oncology, HM Montepríncipe Hospital, Boadilla del Monte, Madrid, Spain., López-Almaraz R; Pediatric Oncology and Hematology, Hospital Universitario Cruces, Bilbao, Spain., Salinas JA; Division of Hematology-Oncology, Department of Pediatrics, Hospital Universitari Son Espases, Palma de Mallorca, Spain., Torres B; Medical Oncology Department, Pediatric Oncology Department, University Hospital La Fe, Valencia, Spain., Hernández F; University Hospital La Paz, Pediatric Surgery Department, Madrid, Spain., Uriz JJ; Pediatric Oncology, Hospital Universitario Donostia, Doctor Begiristain Kalea, 117, 20080, Donostia, Spain., Fabre M; Department of Pathology, Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, and Université Paris Descartes, Paris, France., Blanco J; IrsiCaixa AIDS Research Institute, IGTP, Badalona, Catalonia, Spain; University of Vic - Central University of Catalonia, Vic, Spain., Paris C; Stem Cell Transplant Unit, Hospital Luis Calvo Mackenna, Santiago, Chile., Bajčiová V; Department of Pediatric Oncology, Childrens University Hospital Brno, Brno, Czech., Laureys G; Department of Pediatric Hematology, Oncology and Hematopoietic Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., Masnou H; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain., Clos A; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain., Belendez C; Oncohematology Service, Hospital Gregorio Marañón, Madrid, Spain., Guettier C; Bicêtre Hospital, Le Kremlin-Bicêtre, France., Sumoy L; High Content Genomics and Bioinformatics Unit, PMPPC, IGTP, Badalona, Spain., Planas R; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Gastroenterology Department, Hospital Universitari Germans Trias i Pujol Hospital, Badalona, Spain., Jordà M; PMPPC, IGTP, Badalona, Spain; Consortium for the Study of Thyroid Cancer, CECaT, Barcelona, Spain., Nonell L; MARGenomics, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Czauderna P; Department of Surgery and Urology for Children and Adolescents, Medical University of Gdansk, Gdansk, Poland., Morland B; Department of Oncology, Birmingham Women's and Children's Hospital, Birmingham, UK., Sia D; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA., Losic B; Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, USA; Graduate School of Biomedical Sciences, One Gustave L. Levy Place, Box 1022, New York, NY; Tisch Cancer Institute, Cancer Immunology Program, Icahn School of Medicine at Mount Sinai, New York, NY; Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY., Buendia MA; INSERM, UMR 1193, Paul-Brousse Hospital, Hepatobiliary Centre, Villejuif, France., Sarrias MR; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain; Innate Immunity Group, IGTP, Badalona, Spain., Llovet JM; Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Translational research in Hepatic Oncology, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Armengol C; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain. Electronic address: carmengol@igtp.cat.

Publikováno v: Journal of hepatology [J Hepatol] 2020 Aug; Vol. 73 (2), pp. 328-341. Date of Electronic Publication: 2020 Mar 30.

Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia.

Autor: López-López E; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Odontology, University of the Basque Country (UPV/EHU), Leioa, Spain., Gutiérrez-Camino Á; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Odontology, University of the Basque Country (UPV/EHU), Leioa, Spain., Piñán MÁ; Service of Hematology and Hemotherapy, University Hospital Cruces, Bilbao, Spain., Sánchez-Toledo J; Service of Pediatric Oncology and Hematology, University Hospital Vall d' Hebron, VHIR, Barcelona, Spain., Uriz JJ; Unit of Pediatric Oncohematology, University Hospital Donostia, San Sebastian, Spain., Ballesteros J; Department of Neurosciences, Faculty of Medicine and Odontology, University of the Basque Country (UPV/EHU), Leioa, Spain., García-Miguel P; Service of Pediatric Oncohematology, University Hospital La Paz, Madrid, Spain., Navajas A; Unit of Pediatric Hematology/Oncology, University Hospital Cruces, Bilbao, Spain., García-Orad Á; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Odontology, University of the Basque Country (UPV/EHU), Leioa, Spain.

Publikováno v: PloS one [PLoS One] 2014 Mar 10; Vol. 9 (3), pp. e91261. Date of Electronic Publication: 2014 Mar 10 (Print Publication: 2014).

Longer follow-up confirms major improvement in outcome in children and adolescents with Philadelphia chromosome acute lymphoblastic leukaemia treated with continuous imatinib and haematopoietic stem cell transplantation. Results from the Spanish Cooperative Study SHOP/ALL-2005.

Autor: Rives S, Camós M, Estella J, Gómez P, Moreno MJ, Vivanco JL, Melo M, Fernández-Delgado R, Verdeguer A, Fernández-Teijeiro A, Lendínez F, López-Almaraz R, Uriz JJ, Badell I

Publikováno v: British journal of haematology [Br J Haematol] 2013 Aug; Vol. 162 (3), pp. 419-21. Date of Electronic Publication: 2013 May 14.